Chi Meng Fong
Stock Analyst at Bank of America Securities
(1.86)
# 3,280
Out of 4,520 analysts
38
Total ratings
50%
Success rate
1.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chi Meng Fong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintained: Buy | $21 | $19.91 | +5.47% | 4 | Jun 2, 2026 | |
| ROIV Roivant Sciences | Maintained: Hold | $30 → $32 | $34.51 | -8.72% | 24 | May 25, 2026 | |
| CCCC C4 Therapeutics | Rated: Hold | n/a | $3.69 | n/a | 5 | Oct 31, 2023 | |
| FHTX Foghorn Therapeutics | Rated: Hold | n/a | $5.19 | n/a | 5 | Oct 6, 2023 |
Relay Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $21
Current: $19.91
Upside: +5.47%
Roivant Sciences
May 25, 2026
Maintained: Hold
Price Target: $30 → $32
Current: $34.51
Upside: -8.72%
C4 Therapeutics
Oct 31, 2023
Rated: Hold
Price Target: n/a
Current: $3.69
Upside: n/a
Foghorn Therapeutics
Oct 6, 2023
Rated: Hold
Price Target: n/a
Current: $5.19
Upside: n/a